CARLSBAD, Calif., Oct. 22, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Wednesday, November 6th at 11:30 a.m. Eastern Time to discuss its third quarter 2019 financial results and report on pipeline and business progress.

--- Shipments to commence in December from the Company's Mississauga, Ontario facility TORONTO, Oct. 22, 2019 /PRNewswire/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada

REDWOOD CITY, Calif., Oct. 22, 2019 /PRNewswire/ -- Synthego, the leading genome engineering company, today announced the launch of genome engineering for induced pluripotent stem (iPS

DALLAS, Oct. 22, 2019 /PRNewswire/ -- HealthMine, the health action engagement company, announced Amy Lung has been appointed Chief Operating Officer. Lung is an expert in driving quality improvement through data-driven member and provider engagement strategies. She has extensive experience working between health plans and provider org

OLDWICK, N.J., Oct. 22, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced top-line results from its randomized, placebo-controlled Phase 2a PRINCE clinical trial evaluating twice-daily PRV-6527, an oral Colony Stimulating Factor-1 Receptor

CEDAR KNOLLS, N.J., Oct. 22, 2019 /PRNewswire/ -- MYOS RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), announced today that its Chief Executive Officer, Joseph Mannello, will deliver remarks on Myos Canine Muscle Formula®, the Company's fast-growing Fortetropin-based veterinary product, at the New York Vet Show on

CARY, N.C. and BASEL, Switzerland, Oct. 22, 2019 /PRNewswire/ -- Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug de

REHOVOT, Israel, Oct. 22, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company's Chief Executive Officer Yehiel Tal was recently appointed as a member of the Industry Relations Committee of ISBF (International Society for Biofabrication). The committee convened during the In

SAN JOSE, Calif., Oct. 22, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today an

PLANO, Texas, Oct. 22, 2019 /PRNewswire/ -- ZeOmega, the industry's leading provider of technology-enabled, whole-person health management solutions today announced it has named three industry leaders to its Advisory Board. Joining the Board are David Nash, MD, Founding Dean Emeritus and Dr. Raymond C. and Doris N. Grandon Professor of Heal